Media headlines about Phibro Animal Health Corporation (NASDAQ:PAHC) have trended somewhat positive on Monday, Accern reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Phibro Animal Health Corporation earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.4286313285112 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of equities research analysts have recently weighed in on PAHC shares. Zacks Investment Research upgraded Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research report on Thursday, May 11th. Credit Suisse Group lowered Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price objective for the stock from $29.00 to $36.00 in a research report on Friday, June 2nd. BidaskClub lowered Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Finally, Piper Jaffray Companies set a $35.00 price objective on Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Two analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Hold” and an average price target of $30.50.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, May 8th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. The firm had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. During the same period in the prior year, the business posted $0.38 earnings per share. The company’s revenue for the quarter was up 3.5% on a year-over-year basis.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be issued a $0.10 dividend. The ex-dividend date is Friday, September 1st. This represents a $0.40 annualized dividend and a dividend yield of 1.03%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

In related news, insider Jack Bendheim sold 1,400 shares of the stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $34.04, for a total value of $47,656.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.82, for a total value of $1,671,360.00. Following the completion of the transaction, the insider now directly owns 96,000 shares in the company, valued at approximately $3,342,720. The disclosure for this sale can be found here. Over the last quarter, insiders sold 481,563 shares of company stock worth $16,772,419. Company insiders own 48.09% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Phibro Animal Health Corporation (PAHC) Stock Price” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-phibro-animal-health-corporation-pahc-stock-price.html.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.